💨 Abstract
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter…
Courtesy: wtop.com
Suggested
FEMA ‘not ready’ for hurricane season, internal review says -
Shipment of thousands of chicks found abandoned in USPS truck now overwhelming an animal shelter -
How a new blood test to detect Alzheimer’s disease can stop memory loss earlier -
Lunes de recomendaciones de cine, teatro y series de Catalina Dlugi en La Mañana de CNN -
France’s plan to build a maximum security prison wing in French Guiana angers local officials -
Illinois mulls ending a health program for some immigrants living in the US illegally -
Massachusetts priest returns to public ministry after child rape charges dropped against him -
North Carolina governor urges state lawmakers to include more Helene aid in upcoming budget -
Denzel Washington awarded surprise honorary Palme d’Or in whirlwind stop at Cannes for ‘Highest 2 Lowest’ premiere -
PHOTO GALLERY: Scenes from Gaza -